Cedar vs Pfizer
Side-by-side comparison of AI visibility scores, market position, and capabilities
Cedar is a $3.2B healthcare billing and patient engagement platform; raised $351M led by Tiger Global and a16z; acquired Ooda Health for $425M to expand into insurance payer workflows.
About
Cedar is a New York-based healthcare technology company founded in 2016 by Florian Otto and Arel Lidow. It operates an enterprise platform that modernizes the administrative and billing side of the patient experience — replacing confusing paper bills and phone-based billing departments with a digital-first patient portal that personalizes payment plans, offers price transparency, and drives higher collection rates for healthcare providers.
Global biopharma with $63.6B FY2024 revenue; $43B Seagen ADC acquisition rebuilds post-COVID pipeline; patent cliff 2026-2028 for Eliquis; activist Starboard Value pushing restructuring.
About
Pfizer is one of the world's largest biopharmaceutical companies, founded in 1849 by cousins Charles Pfizer and Charles Erhart in Brooklyn, New York, and now headquartered in New York City. The company trades on NYSE (PFE) and reported $63.6 billion in total revenues for FY2024, normalizing from pandemic highs of $100 billion-plus in 2021-2022 driven by Comirnaty COVID-19 vaccine revenues with BioNTech and Paxlovid COVID antiviral sales. CEO Albert Bourla has led a strategic pivot to reset the company's long-term growth profile, anchored by the landmark $43 billion acquisition of Seagen in December 2023, adding a world-class antibody-drug conjugate (ADC) oncology pipeline including Padcev, Tukysa, Adcetris, and Tivdak.
AI Visibility Head-to-Head
Key Details
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.